s6c-sarafotoxin has been researched along with Leukemia--Megakaryoblastic--Acute* in 2 studies
2 other study(ies) available for s6c-sarafotoxin and Leukemia--Megakaryoblastic--Acute
Article | Year |
---|---|
Endothelin expression in human megakaryoblastic leukemia cell lines and normal platelet precursors.
The aim of the present investigation was to determine whether endothelin (ET) could be expressed in and released from the human leukemia megakaryoblastic cell lines HEL, MEG-01, DAMI and the normal human platelet progenitors. Using the reverse transcriptase-polymerase chain reaction (RT-PCR) on total RNA isolated from the cells, we amplified a cDNA of the expected size (453 bp). Southern-blotting hybridization revealed that RT-PCR products from the cell lines were specific of ET-1 mRNA. Immunocytochemical analyses highlighted immunoreactive ET-1 in the cytoplasm of these cells which also released the mature peptide. ET-1 release from the three cell lines was increased by thrombin exposure. Although MEG-01 cells express ET receptors, ET-1, the selective ETB agonist sarafotoxin 6C and the non-selective ET-receptor antagonist PD 142893 showed no proliferative or antiproliferative action in basal or stimulating medium. This indicated a lack of autocrine ET-mediated effect on growth. These results demonstrate for the first time that human megakaryoblastic leukemia cell lines and normal bone marrow platelet precursors express ET-1 mRNA and release the mature peptide. Topics: Blood Platelets; Blotting, Southern; Cell Division; Endothelin Receptor Antagonists; Endothelin-1; Gene Expression; Hematopoietic Stem Cells; Humans; Immunohistochemistry; Leukemia, Megakaryoblastic, Acute; Megakaryocytes; Oligopeptides; Polymerase Chain Reaction; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; RNA, Messenger; Thrombin; Tumor Cells, Cultured; Viper Venoms | 1997 |
Effects of endothelins on the human megakaryoblastic cell line MEG-01.
Some effects of endothelin-1 (ET-1) were studied on the megakaryoblastic cell line MEG-01. ET-1 induced an elevation of the intracellular levels of Ca2+([Ca2+]i) as measured with the fluorescent indicator indo-1, which consists of an initial transient increase and an ensuing sustained plateau. The plateau phase was abolished by removal of extracellular Ca2+. In addition, ET-1 induced a rapid (within 5 s) increase in the accumulation of inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) and more delayed increases in Ins(1,3,4)P3 and Ins(1,3,4,5)P4, but did not modify cAMP levels. ET-1 homologues (ET-2, ET-3, sarafotoxin 6b and vasointestinal constrictor) also induced biphasic effects on [Ca2+]i. The Ca2+ elevation was concentration dependent, the order of potency being sarafotoxin 6b > ET-1 > ET-2 = vasointestinal constrictor > ET-3. The actions of ET analogs in raising [Ca2+]i were mutually exclusive, suggesting that they act through the same mechanism. These results suggest that cells of the megakaryoblast/megakaryocyte lineage are targets for endothelins. Topics: Calcium; Cell Line; Cyclic AMP; Endothelins; Humans; Inositol Phosphates; Leukemia, Megakaryoblastic, Acute; Megakaryocytes; Tumor Cells, Cultured; Viper Venoms | 1992 |